The Perfect Human Hla-a*02:01&b2m&ny-eso-1 (sllmwitqc) Tetramer Protein (mhc-he446t) Device [gSzU9hCG]

Human HLA-A*02:01&B2M&NY-ESO-1 Tetramer Protein

The Human HLA-A*02:01&B2M&NY-ESO-1 Tetramer Protein (MHC-HE446T) is a cutting-edge research tool designed for immunology and oncology studies. This high-quality protein tetramer is meticulously engineered to present the NY-ESO-1 epitope (SLLMWITQC) on the HLA-A*02:01 background, making it an invaluable asset for researchers investigating immune responses and cancer vaccines.

• High Specificity: The tetramer ensures precise epitope presentation, allowing for accurate identification of immune responses.
• High Purity: Our protein tetramer is produced through a stringent purification process, guaranteeing minimal contamination and optimal performance.

Product Properties and Specifications

The Human HLA-A*02:01&B2M&NY-ESO-1 Tetramer Protein is formulated with exceptional purity and stability. It is suitable for a variety of applications, including flow cytometry, ELISA, and immunohistochemistry. Key specifications include:

• Epitope Presentation: The NY-ESO-1 epitope (SLLMWITQC) is presented on the HLA-A*02:01 background.
• Storage: Store at 4°C for long-term stability; -20°C for short-term storage.
• Concentration: 1 mg/mL in PBS with 0.1% sodium azide.

This product is designed to meet the highest standards of quality control, ensuring reliable results in your research endeavors.

Practical Uses and Target Audience

The Human HLA-A*02:01&B2M&NY-ESO-1 Tetramer Protein is an essential tool for researchers in the fields of immunology and oncology. Its practical applications include:

• Immunology Research: Studying immune responses to the NY-ESO-1 epitope.
• Cancer Vaccine Development: Assessing the efficacy of cancer vaccines targeting the NY-ESO-1 epitope.

This product is particularly beneficial for researchers working on personalized medicine, as it allows for the identification of specific immune responses in patients. By using this tetramer, you can advance your research and contribute to the development of novel therapeutic strategies for cancer and other immune-related disorders.